T1	p 124 141	type 1 diabetes .
T2	p 562 628	24 patients , 8-18 years old , with newly diagnosed T1D . Subjects
T3	p 706 724	diagnosis of T1D .
T4	i 6 26	Insulin pump therapy
T5	i 320 340	insulin pump therapy
T6	i 485 556	MDI therapy with continuous subcutaneous insulin therapy ( pump therapy
T7	i 1614 1626	insulin pump
T8	i 1808 1812	pump
T9	o 73 81	glycemic
T10	o 183 218	residual insulin secretory capacity
T11	o 738 816	of insulin secretion , measured by mixed-meal-stimulated C-peptide secretion ,
T12	o 896 1037	glycosylated hemoglobin ( HbA1c ) , continuous glucose sensor data , insulin utilization , anthropometric measures , and patient satisfaction
T13	o 1191 1244	mixed-meal tolerance test-stimulated C-peptide values
T14	o 1353 1369	glycemic control
T15	o 1439 1452	normoglycemia
T16	o 1462 1474	mean HbA1c )
T17	o 1481 1493	pump-treated
T18	o 1534 1546	satisfaction
T19	o 1657 1673	glycemic control
T20	o 1685 1694	tolerated
T21	o 1725 1745	patient satisfaction
T22	o 1853 1859	?-cell